On Thursday, Walgreens Boots Alliance Inc (NASDAQ: WBA) reported third-quarter fiscal year 2024 sales of $36.35 billion, up 2.6% year over year (+2.5% on constant currency), beating the consensus of $36 billion. Adjusted operating income was $613 million, a decrease of 36.3% on a constant currency basis, reflecting lower sale-leaseback gains and softer U.S. retail and pharmacy performance, partly offset by cost savings initiatives and improved profitability in the U.S. Healthcare segment. Adjusted EPS was $0.63, down 36.6% on both a reported and constant currency basis, missing the consensus of $0.71, according to data from Benzinga Pro. The U.S. Retail Pharmacy segment had third-quarter sales of $28.5 billion, up 2.3%, driven entirely by comparable pharmacy sales, partly ...